Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 19, 2022
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
How zinc boosts the immune system
In mice, mineral improves regeneration of key immune organ and immune-cell recovery after bone marrow transplant
Mourning the loss of James Raisbeck, Hutch supporter and aviation leader
Four Raisbeck endowed chairs continue long legacy of advancing biomedical science
Coronavirus: what cancer patients need to know
Advice for cancer patients, survivors and caregivers on who’s most at risk for COVID-19 and what you can do to stay healthy
How a phone call helped shape the field of bone marrow transplant
A lifesaving new leukemia treatment was harming some patients’ digestive organs, and no one really understood why. So, over 40 years, Dr. George McDonald helped fill in the gaps.
What’s new in combatting chronic graft-vs.-host disease
Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects
KUOW profiles E. Donnall Thomas and his Nobel Prize-winning work on a once 'radical' cure for leukemia
Fred Hutch research in bone marrow transplantation helped establish Seattle's biotech industry
Dr. Carl June weaves together HIV and cancer research to advance cures for both
CAR T-cell pioneer and one-time bone marrow transplant fellow will give keynote at HIV cure conference
What we can learn about global flu evolution from individual infections
Study of 10-year-old flu samples finds virus’s evolution in individual transplant patients partially mirrors later global trends
Bezos family gives $35 million to Fred Hutch
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
30 years after a bone marrow transplant, a cancer survivor looks back
30 years after an early BMT, a cancer survivor pays it forward by helping researchers ‘make it better for others’
Fred Hutch holiday gala raises more than $13 million for pediatric cancer research
Fred Hutch Holiday Gala brings in more than $13 million to grow pediatric cancer research and develop needed therapies for children
Common genetic disorder linked to increased death rate from cancer drug
Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome
Physician-scientist Dr. Bruce Clurman named executive vice president and deputy director of Fred Hutch
Clurman will focus on team science, interdisciplinary collaboration in pursuit of new cures, said President and Director Dr. Gary Gilliland
Stem cells from bone marrow may be better than blood when it comes to quality of life for transplant patients, study suggests
New study explores whether stem cells from bone marrow or blood offer transplant patients better quality of life
Can Timothy Ray Brown’s HIV cure be repeated?
'Patient B' joined a Boston research study to find out: Gary Steinkohl’s story — and legacy
When do we say cure for cancer?
A loaded word for cancer patients, but researchers view ‘cure’ through lens of statistics
Experts from leading cancer centers ask, ‘Where’s the outcry?’
Antiviral drug for post-transplant complications now costs more than the transplant